MX2014015199A - Formulacion de pexiganan estable. - Google Patents

Formulacion de pexiganan estable.

Info

Publication number
MX2014015199A
MX2014015199A MX2014015199A MX2014015199A MX2014015199A MX 2014015199 A MX2014015199 A MX 2014015199A MX 2014015199 A MX2014015199 A MX 2014015199A MX 2014015199 A MX2014015199 A MX 2014015199A MX 2014015199 A MX2014015199 A MX 2014015199A
Authority
MX
Mexico
Prior art keywords
formulation
stable
stable pexiganan
pexiganan formulation
pexiganan
Prior art date
Application number
MX2014015199A
Other languages
English (en)
Other versions
MX345263B (es
Inventor
Nayan Desai
Original Assignee
Dipexium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipexium Pharmaceuticals Inc filed Critical Dipexium Pharmaceuticals Inc
Publication of MX2014015199A publication Critical patent/MX2014015199A/es
Publication of MX345263B publication Critical patent/MX345263B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

La invención proporciona formulaciones tópicas químicamente y físicamente estables de pexiganan, y métodos para preparar las mismas.
MX2014015199A 2012-06-12 2013-06-10 Formulación de pexiganan estable. MX345263B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/494,295 US8530409B1 (en) 2012-06-12 2012-06-12 Stable pexiganan formulation
PCT/US2013/044957 WO2013188286A1 (en) 2012-06-12 2013-06-10 Stable pexiganan formulation

Publications (2)

Publication Number Publication Date
MX2014015199A true MX2014015199A (es) 2015-08-14
MX345263B MX345263B (es) 2017-01-23

Family

ID=49084089

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014015199A MX345263B (es) 2012-06-12 2013-06-10 Formulación de pexiganan estable.

Country Status (27)

Country Link
US (2) US8530409B1 (es)
EP (1) EP2858721B1 (es)
JP (1) JP5876191B2 (es)
KR (1) KR101622524B1 (es)
CN (1) CN104602762B (es)
AU (1) AU2013274561B2 (es)
BR (1) BR112014030993A2 (es)
CA (1) CA2876668C (es)
CY (1) CY1118277T1 (es)
DK (1) DK2858721T3 (es)
EA (1) EA028002B1 (es)
ES (1) ES2599395T3 (es)
HK (1) HK1210078A1 (es)
HR (1) HRP20161440T1 (es)
HU (1) HUE030665T2 (es)
IL (1) IL236151A (es)
LT (1) LT2858721T (es)
MX (1) MX345263B (es)
NZ (1) NZ703176A (es)
PL (1) PL2858721T3 (es)
PT (1) PT2858721T (es)
RS (1) RS55286B1 (es)
SG (1) SG11201408055PA (es)
SI (1) SI2858721T1 (es)
SM (1) SMT201600411B (es)
WO (1) WO2013188286A1 (es)
ZA (1) ZA201500117B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
GB201505393D0 (en) * 2015-03-30 2015-05-13 Secr Defence Antimicrobal peptide formulations
CN111925430B (zh) * 2020-08-18 2022-05-24 中国海洋大学 抗菌肽及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4169703A (en) * 1978-08-03 1979-10-02 Syntex (U.S.A.) Inc. Oxidative red hair dye
US5912231A (en) * 1989-07-07 1999-06-15 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
AP2006003784A0 (en) * 2004-03-18 2006-10-31 Panacea Biotec Ltd Novel compositions for topical delivery
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2009070564A2 (en) * 2007-11-27 2009-06-04 Macrochem Corporation Compositions and methods for prevention of infection in transcutaneous osseointegrated implants
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
WO2012174373A1 (en) * 2011-06-16 2012-12-20 Dipexium Pharmaceuticals Methods of treating and inhibiting pathogens with resistance-mechanisms
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation

Also Published As

Publication number Publication date
AU2013274561B2 (en) 2015-09-10
MX345263B (es) 2017-01-23
KR20150043286A (ko) 2015-04-22
SG11201408055PA (en) 2015-01-29
ES2599395T3 (es) 2017-02-01
HK1210078A1 (en) 2016-04-15
US20140038882A1 (en) 2014-02-06
RS55286B1 (sr) 2017-03-31
CN104602762B (zh) 2017-04-05
LT2858721T (lt) 2016-12-12
EP2858721A1 (en) 2015-04-15
PL2858721T3 (pl) 2017-02-28
CN104602762A (zh) 2015-05-06
IL236151A0 (en) 2015-01-29
US8530409B1 (en) 2013-09-10
EA028002B1 (ru) 2017-09-29
BR112014030993A2 (pt) 2017-06-27
JP2015521599A (ja) 2015-07-30
JP5876191B2 (ja) 2016-03-02
ZA201500117B (en) 2016-10-26
IL236151A (en) 2016-06-30
PT2858721T (pt) 2016-11-17
EA201492280A1 (ru) 2015-05-29
WO2013188286A1 (en) 2013-12-19
HRP20161440T1 (hr) 2016-12-16
EP2858721B1 (en) 2016-08-17
HUE030665T2 (en) 2017-05-29
CA2876668A1 (en) 2013-12-19
CY1118277T1 (el) 2017-06-28
SMT201600411B (it) 2017-01-10
DK2858721T3 (en) 2016-11-28
CA2876668C (en) 2017-12-05
NZ703176A (en) 2015-08-28
KR101622524B1 (ko) 2016-05-18
EP2858721A4 (en) 2015-12-09
AU2013274561A1 (en) 2015-01-22
SI2858721T1 (sl) 2017-01-31

Similar Documents

Publication Publication Date Title
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2016008448A (es) Conjugados de var2csa-farmaco.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
PH12014502601A1 (en) ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
PH12016500316A1 (en) Improved adenovirus formulations
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
JO3755B1 (ar) تركيبات تستوستيرون
TN2015000411A1 (en) Ceftolozane antibiotic compositions
EP3038611A4 (en) Novel 2,4-dinitrophenol formulations and methods using same
PL2841549T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
PL2841548T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
CA2875305C (en) Fbxo3 inhibitors
SG10201900598TA (en) Factor viii formulation
EP3043786A4 (en) Cationic antiseptic compositions, method and kit
PL2961822T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP3068436A4 (en) Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine
MX362155B (es) Combinaciones de alquilamidotiazoles y sustancias aromaticas.
MX368268B (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
PL2989192T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
WO2014146111A3 (en) Analgesic compounds and methods of use
MX2014015199A (es) Formulacion de pexiganan estable.
AU2013338098A8 (en) Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
EP2945703A4 (en) ALBU-BCHE FORMULATIONS, PREPARATION THEREOF AND USES THEREOF

Legal Events

Date Code Title Description
FG Grant or registration